ARNI Projected Dividend Yield
Arno Therapeutics, Inc. ( OTCBB : ARNI )Arno Therapeutics is an early stage enterprise engaged in developing products for the treatment of cancer and other diseases. As of Dec 31 2015, Co.'s product development pipeline consisted of: Onapristone, which is an anti-progestin hormone blocker that has been shown to have considerable anti-tumor activity in patients with breast cancer; AR-12, which is an orally available cancer treatment that has been shown in clinical studies to inhibit multiple different kinase targets; and AR-42, which is an oral cancer therapy and a deacetylase inhibitor of both histone and non-histone proteins, which has demonstrated activity in solid tumors and hematological malignancies. 20 YEAR PERFORMANCE RESULTS |
ARNI Dividend History Detail ARNI Dividend News ARNI Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |